2026 Prize Winners
The 2026 Rowley Prize
The iCMLf is pleased to announce that Professor Junia Vaz de Melo, Professor of Medicine at Adelaide University, Australia, has been awarded the 2026 iCMLf Rowley Prize. The award recognises her lifetime contributions to advancing the biological understanding of CML. Over several decades, Professor Vaz de Melo has made important discoveries towards elucidation of the molecular mechanisms underlying CML, leading to the translation of these insights into improved strategies for diagnosis and treatment.
"Junia is an exceptionally worthy recipient of the Rowley Prize, due to her substantial contributions that have profoundly improved the understanding of the molecular biology of CML, which hold enduring significance and consequences. She played a pivotal role in the foundational research that led to the first clinical trials for BCR::ABL1 targeted therapy and published one of the earliest studies that illustrated acquired resistance to imatinib in CML cells. This research paved the way to investigations on the mechanisms of such resistance in patients and the development of second-generation tyrosine kinase inhibitors"
- Professor Susan Branford
Read more
The 2026 Goldman Prize
The iCMLf is delighted to announce that Professor Meinolf Suttorp, a
Senior Professor of Pediatric Hematology and Oncology from Dresden, Germany, is the recipient of the 2026 John Goldman Prize, in recognition of his outstanding and sustained contributions to the understanding and treatment of pediatric CML. The iCMLf John Goldman Prize recognises individuals whose work has significantly advanced the understanding and management of CML worldwide.
For decades, Professor Suttorp has been at the forefront of research and clinical care for children and adolescents with CML. Through his scientific leadership, international collaboration, and commitment to improving patient outcomes worldwide, he has helped establish the foundations of modern pediatric CML care.
"Professor Meinolf Suttorp has made transformative contributions to the field of chronic myeloid leukemia, particularly through his pioneering work in pediatric CML. His leadership in international collaborative trials, unwavering commitment to improving outcomes for children, and his strong dedication to patient advocacy have set new standards for care.
His work exemplifies the very spirit of the John Goldman Prize."
- Professor Andreas Hochhaus
Read more
The 2026 iCMLf Prize
In many parts of the world, progress in the treatment of CML depends not only on scientific advances, but on individuals who translate those advances into a reality for patients. Associate Professor Amha Gebremedhin, recently retired Consultant Internist and Hematologist at Addis Ababa University and Tikur Anbessa Specialized Hospital in Ethiopia, is one such individual. Over a distinguished career dedicated to the care of his patients, education for colleagues, and building capacity at his hospital, he has played a transformative role in advancing CML management in Ethiopia and beyond.
"In this context, Dr Gebremedhin emerges as an outstanding figure, having provided medical care and support for patients with CML during a period of significant economic and social hardship in Ethiopia, characterized by wars and ethnic tensions. He has achieved this while maintaining contact with the international scientific community on both diagnostic and therapeutic matters."
- Professor Giuseppe Saglio
Read more
> Previous winners | Keynote speeches